Reply to SGLT-2 inhibitors: Post-infarction interventional effects.
Paolisso P, Bergamaschi L, Gragnano F, Gallinoro E, Cesaro A, Sardu C, Mileva N, Foà A, Armillotta M, Sansonetti A, Amicone S, Impellizzeri A, Esposito G, Morici N, Andrea OJ, Casella G, Mauro C, Vassilev D, Galie N, Santulli G, Marfella R, Calabrò P, Barbato E, Pizzi C.
Paolisso P, et al. Among authors: barbato e.
Pharmacol Res. 2023 Mar;189:106664. doi: 10.1016/j.phrs.2023.106664. Epub 2023 Jan 13.
Pharmacol Res. 2023.
PMID: 36642618
Free PMC article.
No abstract available.